In this short video, RGA’s Dr. Daniel Zimmerman discusses the rapidly developing technology of liquid biopsies. He defines what they are, what impact they will likely have on clinical medicine, and how they might impact insurers.
RGA webcast series | part 1/4 In this first in a series of four webcasts, Peter Banthorpe, Global Head of Research and Data Analytics at RGA, discusses the huge growth in direct-to-consumer (DTC) genetic testing, regulatory policies to control genetic dis
RGA webcast series | part 2/4 Dr Richard Russell, Lead Health Data Scientist at RGA, explores the latest genetics research concerning human susceptibility to disease and examines the pertinent question: can genetic information transform clinical risk asse
RGA webcast series | part 3/4 Professor Cathryn Lewis, from King’s College London, outlines details of a research collaboration with RGA investigating the importance of genetic information to predict morbidity and mortality outcomes. Professor Lewis
RGA webcast series | part 4/4 Peter Banthorpe, Global Head of Research and Data Analytics at RGA, discusses the results of RGA’s research study with King’s College London and the implications for genetic anti-selection in protection insurance.